5 Challenges faced by Pharma Industry

1. 5 Reasons Why Pharma Industry Is Not Going To Be That Rosy India is a major player on the global platform as far as production of pharmaceutical products is concerned. The pharma industry is growing rapidly and is going to reach newer heights in the years to come. The scope of growth in this sector has attracted many foreign and domestic players to enter this booming industry. Though there are many positive signs which are contributing towards the success of pharma industry, there are a few negative ones too. The years ahead are not going to be very rosy for this industry. Listed below are some of the speed breakers on the road of glory for pharma companies. 1. Industry Standards Compliance & Good Manufacturing Practices: This has been the most common issue faced by pharma companies in India. Adding to the misery is the United States Food and Drug Administration (USFDA) norms. The approval of this body is very important because US is the largest consumer and India is a major exporter of pharma products. All the indian pharma companies are trying their best to comply with the standard of USFDA. Going in tune with the stringent rules is a daunting task for the indian companies. 2. The Fragmentation Problem: Another major problem of indian pharma industry is the fragmentation of the companies. The generic manufacturers have overloaded the indian market. High level of fragmentation in the market causes a sense of instability, volatility and uncertainty. The pharma companies have to review their policies at regular interval so that they can survive in the volatile market. The operational element of the companies should be taken care to tackle this issue. 3. Profit Margin Is Very Low: The rising cost of the raw materials have decreased the profit margin considerably. The pharma companies have to be satiated within peanuts when it comes to profit as compared to other industry. The various reforms by the government to Pharmaceutical Raw Material Company

2. 5 Reasons Why Pharma Industry Is Not Going To Be That Rosy reduce the costs of the drugs has further reduced the profit margin. The government should come up with a plan which will be beneficial for both the public and the pharma companies. 4. Less Investment Towards Research & Development: Since the profit margin is not much, companies in this sector are less inclined towards spending more on research and development. Less expenditure on research and development leads to lower quality of products at higher costs. The consumer is also at the receiving end because the options available in the market is limited. The low income for the companies have urged them to stay away from investing heavily on better technology and skills. Tatva Chintan Pharma Chem Pvt. Ltd, a leading raw material supplier for various pharmaceuticals companies in India and abroad has a wide variety of various chemical products like specialty chemicals, quaternary phosphonium salts, methylating agents, electrolyte chemicals, etc. It has made a name for itself with the kind of quality it provides at such a competitive price. The quality product supplied by them at such an affordable price has made them a big hit in the industry. Pharmaceutical Raw Material Company